Status:
COMPLETED
Amphotericin B Treatment in Visceral Leishmaniasis
Lead Sponsor:
Banaras Hindu University
Conditions:
Visceral Leishmaniasis
Eligibility:
All Genders
2-65 years
Phase:
NA
Brief Summary
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way e...
Detailed Description
This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way e...
Eligibility Criteria
Inclusion
- Parasitologically proved kala-azar
Exclusion
- HIV positive serology
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00310505
Start Date
January 1 2003
Last Update
September 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kala-azar Medical Research Center
Muzaffarpur, Bihar, India, 221005